No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditions
|
516672 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1403 |
4. Check minimum number of eventsNone |
1403 |
5. Include endpointsNone |
1403 |
6. Filter based on genotype QC (FinnGen only) |
1358 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D09
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, bladder
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1358 | 272 | 1086 |
| Unadjusted period prevalence (%) | 0.42 | 0.10 | 0.50 |
| Median age at first event (years) | 72.83 | 69.42 | 73.68 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1403
- Matched controls
- 14030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ZX136
NOMESCO Finland
Intravesicalis
43.5
317.0
192
51
KCD02
NOMESCO Finland
Transurethral resection of bladder
127.5
307.7
930
213
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
75.9
307.7
569
125
R31
ICD-10 Finland
Unspecified haematuria
11.8
307.7
817
1477
UKC02
NOMESCO Finland
Cystoscopy
61.1
307.7
1295
2302
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
137.6
307.7
867
163
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
6813.9
307.7
997
5
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
139.9
307.7
894
174
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
143.0
307.7
685
93
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
36.8
307.7
224
72
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
67.4
307.7
398
82
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
90.1
307.7
410
64
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
76.7
210.2
113
16
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
23.0
209.3
156
76
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
881.1
163.1
157
*
KCW96
NOMESCO Finland
Other operations on bladder
34.3
154.7
99
31
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
44.0
138.9
83
20
KH1AD
NOMESCO Finland
CT of urinary organs
8.0
133.5
196
280
C67
ICD-10 Finland
Malignant neoplasm of bladder
47.9
131.4
77
17
WX320
NOMESCO Finland
Spinalanesthesy
3.8
130.9
667
2703
U06
ICPC
Haematuria
7.7
128.9
196
291
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
1345.9
128.2
123
*
XKD00
NOMESCO Finland
Uroflowmetry
3.1
92.2
613
2793
KH1DD
NOMESCO Finland
CT urography of urinary organs
30.3
92.1
61
21
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
91.9
274
744
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
14.9
91.9
83
59
UKB02
NOMESCO Finland
Retrograde ureteroscopy
12.5
87.5
88
75
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.0
83.0
525
2300
WX402
NOMESCO Finland
General anaesthesia
3.0
75.1
463
1982
TKC20
NOMESCO Finland
Catheterisation of bladder
3.8
74.2
262
796
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.7
70.1
116
186
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
10.4
69.8
79
80
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
36.9
68.8
43
12
WX224
NOMESCO Finland
Blockade of obturius nerve
149.4
67.6
71
5
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
19.6
65.1
51
27
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
8.6
63.3
83
102
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.0
59.3
333
1333
KCB00
NOMESCO Finland
Biopsy of bladder
19.6
53.8
42
22
J01MA02
ATC
ciprofloxacin; systemic
2.3
52.3
753
4653
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
50.0
502
2644
U76
ICPC
Malignant neoplasm of bladder
19.5
48.5
38
20
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
47.1
45
*
N30.0
ICD-10 Finland
Acute cystitis
2.8
46.4
269
1083
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.4
44.2
75
123
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
16.8
42.8
36
22
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
216.3
41.1
42
*
KED22
NOMESCO Finland
Transurethral resection of prostate
2.8
40.5
238
961
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
36.9
301
1420
ZXC20
NOMESCO Finland
Use of chemical agents
4.8
35.6
83
182
KDV10
NOMESCO Finland
Internal urethrotomy
5.4
35.1
70
134
G04BD12
ATC
mirabegron; oral
2.4
35.1
290
1373
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
35.0
281
1313
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
6.1
34.5
61
104
U07
ICPC
Urine symptom/complaint other
2.7
32.1
192
777
4CX01, ,
NOMESCO Finland
168.8
31.8
33
*
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
31.4
30
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.5
29.8
75
175
G04CA02
ATC
tamsulosin; oral
1.9
29.6
691
4757
ZXE00
NOMESCO Finland
One hour or less
1.9
29.5
594
3897
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
10.5
29.0
32
31
A98
ICPC
Health maint/preventive medicine
4.3
28.2
1349
11980
JN4AD
NOMESCO Finland
Body CT examination
2.2
27.8
274
1386
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
27.0
301
1596
R33
ICD-10 Finland
Retention of urine
2.2
26.6
249
1232
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
31.7
23.8
31
10
KBV10
NOMESCO Finland
Removal of stent from ureter
6.6
23.1
37
57
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
84.9
22.7
25
*
N30.9
ICD-10 Finland
Cystitis, unspecified
2.9
22.5
111
404
C66
ICD-10 Finland
Malignant neoplasm of ureter
24.4
22.2
31
13
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.5
22.1
77
227
N02BE01
ATC
paracetamol; systemic, rectal
2.4
21.3
1272
11229
J01DB01
ATC
cefalexin; oral
1.9
20.3
1139
9694
KCD30
NOMESCO Finland
Destruction of tumour of bladder
23.8
20.0
28
12
J01EA01
ATC
trimethoprim; systemic
1.9
19.8
314
1863
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.2
19.8
53
130
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
74.6
19.7
22
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.7
19.5
45
98
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.6
18.8
45
101
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
16.9
805
6370
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
16.7
16
*
WZC30
NOMESCO Finland
Teaching
1.8
16.5
282
1704
U29
ICPC
Urinary symptom/complaint other
2.9
16.0
75
265
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
15.7
15
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
5.8
15.4
28
49
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
20.3
15.1
22
11
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
15.0
921
7640
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.6
14.9
24
37
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
151.5
14.5
15
*
WX702
NOMESCO Finland
Supraglottic ventilation device
2.5
14.4
92
382
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
6.8
14.0
22
33
J01MA12
ATC
levofloxacin; systemic
1.7
13.8
322
2114
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
13.8
110
505
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
13.7
506
3714
B02AA02
ATC
tranexamic acid; systemic
2.1
13.6
138
697
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
13.6
13
*
UKD02
NOMESCO Finland
Urethroscopy
5.9
13.5
24
41
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
18.4
13.4
20
11
N21.0
ICD-10 Finland
Calculus in bladder
4.0
13.3
38
98
SPAT1262
SPAT
Handing over of treatment supplies
1.7
13.2
308
2019
G04CA01
ATC
alfuzosin; oral
1.7
13.2
330
2204
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
12.5
516
3864
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
24.5
12.5
17
7
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
12.4
447
3247
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
12.3
244
1529
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
12.3
853
7109
SPAT1263
SPAT
Sampling
1.5
12.1
565
4335
KBH20
NOMESCO Finland
Replantation of ureter
21.5
12.0
17
8
Z3231
NOMESCO Finland
Registered nurse
1.6
11.7
396
2830
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
4.1
11.7
32
80
TKD00
NOMESCO Finland
Dilatation of urethra
4.6
11.7
27
59
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
23.1
11.6
16
7
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
11.5
596
4655
U01
ICPC
Dysuria/painful urination
2.3
11.5
91
416
A02BC02
ATC
pantoprazole; systemic
1.5
11.3
953
8193
8130/1-C67.9
ICD-O-3
Papillary urothelial neoplasm of low malignant potential of bladder, NOS
25.2
11.1
15
6
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
11.1
557
4314
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.4
11.0
39
117
U05
ICPC
Urination problems other
2.0
11.0
114
581
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
10.9
166
961
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
8.9
10.8
22
25
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.6
10.7
292
1980
R39.1
ICD-10 Finland
Other difficulties with micturition
2.4
10.6
72
308
KDE20
NOMESCO Finland
Removal of foreign body from urethra
4.0
10.6
30
77
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
10.5
653
5257
U13
ICPC
Bladder symptom/complaint other
2.7
10.2
53
199
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.8
10.2
50
182
G04BD08
ATC
solifenacin; oral
2.0
10.1
117
619
KH1AE, ,
SPAT
3.4
9.9
35
105
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
9.8
343
2455
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
9.8
421
3146
SPAT1167
SPAT
Insertion of urinary catheter
2.3
9.8
77
352
S18
ICPC
Laceration/cut
1.4
9.7
703
5788
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.5
9.7
63
264
K02.1
ICD-10 Finland
Caries of dentine
1.4
9.7
675
5518
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
9.6
201
1274
U08
ICPC
Urinary retention
2.4
9.6
62
260
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
9.2
9.5
19
21
OAB50, ,
SPAT
1.8
9.5
140
802
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
9.4
310
2188
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
9.4
215
1394
G04CB01
ATC
finasteride; oral
1.5
9.4
299
2096
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.3
9.3
34
104
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.2
592
4756
U02
ICPC
Urinary frequency/urgency
1.7
9.0
178
1109
J01CA04
ATC
amoxicillin; systemic
1.5
8.9
1027
9131
T90
ICPC
Diabetes non-insulin dependent
1.5
8.8
413
3127
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.2
8.7
20
28
TKC22
NOMESCO Finland
Catheterisation instruction
2.3
8.7
62
272
KA3EB
NOMESCO Finland
Antegrade pyelography
4.8
8.6
19
40
WX720
NOMESCO Finland
Own respiration
2.1
8.5
79
386
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
8.4
398
3017
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
8.1
505
4010
KCC10
NOMESCO Finland
Cystoprostatectomy
4.0
8.1
22
55
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
8.0
192
1257
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.0
627
5175
KGH10
NOMESCO Finland
Operation for phimosis
2.2
7.9
63
290
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.9
730
6182
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
3.3
7.8
29
90
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
7.7
65
307
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
7.7
494
3940
Z01.2
ICD-10 Finland
Dental examination
1.4
7.6
494
3945
KBD00
NOMESCO Finland
Partial excision of ureter
25.2
7.6
10
*
4078, ,
NOMESCO Finland
80.5
7.4
8
*
U70
ICPC
Pyelonephritis/pyelitis
3.2
7.4
28
88
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.3
963
8582
-1, ,
NOMESCO Finland
1.4
7.3
342
2575
8130/2-C67.1
ICD-O-3
Papillary urothelial carcinoma, non-invasive of dome of bladder
+∞
7.3
7
*
D06
ICPC
Abdominal pain localized other
1.8
7.2
99
555
KBV00
NOMESCO Finland
Insertion of stent into ureter
5.8
7.2
19
33
A03
ICPC
Fever
1.6
7.1
170
1111
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.0
399
3105
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
404
3154
KED33
NOMESCO Finland
Transurethral incision of prostate
2.5
7.0
41
165
P17
ICPC
Tobacco abuse
3.7
6.9
21
57
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.6
6.9
152
976
SFA20
NOMESCO Finland
Two-surface restoration
1.3
6.8
644
5425
RD211, ,
NOMESCO Finland
2.1
6.8
62
302
JN4CD
NOMESCO Finland
Very extensive body CT
2.0
6.8
69
350
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
6.8
119
719
WVA20
NOMESCO Finland
Medicine administration
2.3
6.8
51
230
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
40.2
6.8
8
*
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.4
6.7
281
2070
KBB00
NOMESCO Finland
Biopsy of ureter
22.6
6.7
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
6.6
329
2499
H13
ICPC
Plugged feeling ear
1.4
6.6
319
2410
G04CB02
ATC
dutasteride; oral
1.5
6.6
209
1458
WX290
NOMESCO Finland
Other blockage of nerve
1.4
6.5
470
3796
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.8
6.5
99
575
J01CA08
ATC
pivmecillinam; oral
1.5
6.5
261
1909
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.4
121
745
SPAT1312
SPAT
General health counselling
1.4
6.4
381
2981
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.9
6.4
81
444
SPAT1325
SPAT
Vaccination
1.4
6.4
486
3955
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
6.3
93
534
KC1GD
NOMESCO Finland
CT cystography of bladder
11.1
6.3
11
10
N30
ICD-10 Finland
Cystitis
2.0
6.3
68
353
H60.8
ICD-10 Finland
Other otitis externa
2.4
6.2
42
181
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
0.0
6.2
*
155
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.0
6.1
67
349
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.1
6.1
58
288
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
3.4
6.0
21
63
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
No TimeCodeWAS data yet for this endpoint. Try one of these:
- AB1_ASPERGILLOSIS
- AB1_CHLAMY_OTHER
- AB1_EARLY_SYPHILIS
- AB1_EARLY_SYPHILIS_WIDE
- AB1_EBV
- AB1_HIV_NOS
- AB1_INFECT_PARASIT_WIDE
- AB1_LATE_SYPHILIS_WIDE
- AB1_LYME_WIDE
- AB1_MUMPS_WIDE
- AB1_OTHER_PROTOZOAL
- AB1_OTHER_SPIROCHAETAL
- AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST
- AB1_PEDICULOSIS_AND_PHTHIRIAASIS_WIDE
- AB1_PNEUMOCYSTOSIS
- AB1_SEPSIS_BACT_IMPL_WIDE
- AB1_SEPSIS_PARAS_IMPL
- AB1_SEQULAE_POLIO
- AB1_SEXUAL_TRANSMISSION_NOS
- AB1_STREPTO_SEPSIS
- AB1_SYPHILIS_NOS_WIDE
- AB1_TICK_BORNE_ENCEPHALITIS
- AB1_TICK_BORNE_ENCEPHALITIS_WIDE
- AB1_TOXOPLASMOSIS_WIDE
- AB1_VARICELLA
- AB1_VIRAL_HEPATITIS
- AB1_VIRAL_INOTHER_WIDE
- AB1_YAWNS
- AD_U
- AMN2
- ANY_CANC
- ANY_REIMB
- ASTHMA_NOS
- ASTHMA_PNEUMONIA_AND_SEPSIS
- AUD
- C3_ACCESSORY_SINUS_WIDE
- C3_AML_WIDE
- C3_BASAL_CELL_CARCINOMA
- C3_BASEOFTONGUE_WIDE
- C3_CHONDROSARCOMA
- C3_COLORECTAL
- C3_COLORECTAL_ADENO
- C3_DIGESTIVE_ORGANS_NAS
- C3_EYE_BRAIN_NEURO_WIDE
- C3_FOLLICULAR_LYMPHOMA
- C3_GASTRINT_STROM
- C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE
- C3_MANTLE_CELL_LYMPHOMA_WIDE
- C3_NONFOLLICULAR_LYMPHOMA
- C3_NSCLC_ADENO
- C3_NSCLC_SQUAM
- C3_PENIS_WIDE
- C3_RENAL_CELL_CARCINOMA
- C3_SALIVARYNAS_WIDE
- C3_SCLC
- C3_SMALL_INTESTINE_ADENO
- C3_TESTIS
- C3_TONGUENAS_WIDE
- C3_UNCERTAIN_SECONDARY
- C3_URETER
- C3_URETER_WIDE
- CD2_BENIGN_BRAIN_CNS
- CD2_BENIGN_BRONCHUS_LUNG
- CD2_BENIGN_CONNSOFT_NOS
- CD2_BENIGN_CONNSOFT_UPPERLIMB
- CD2_BENIGN_DESCENDING_COLON
- CD2_BENIGN_ENDOCRINE_OTH
- CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA
- CD2_BENIGN_MELANOCYTIC_EAR
- CD2_BENIGN_MELANOCYTIC_LOWERLIMB
- CD2_BENIGN_MENINGES_SPINAL
- CD2_BENIGN_OESOPHAGUS
- CD2_BENIGN_OROPHA_OTHER
- CD2_BENIGN_PROSTATE
- CD2_BENIGN_RETROPERITONEUM_PERITONEUM
- CD2_BENIGN_SKIN_EYELID
- CD2_INSITU_BREAST_NOS
- CD2_INSITU_LARYNX
- CHIRBIL_NAS
- CHRONHEP_NAS
- COLITCOLLAG
- COLITENTER
- C_STROKE
- D3_ANAEMIA_B12_DEF
- D3_BLOODNAS
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
- D3_COMBIMMUDEF
- D3_COMPLEMENTDEF
- D3_HEREDFVIIIDEF
- D3_HYPERSPLENISM
- D3_NEFELOF
- D3_NONAIHA_OTHER
- D3_SCNDPOLYCYTHAEMIA
- D3_SICKLECELLDIS
- D3_SIDEROANAEMIAHERED
- D3_THALASSAEMIA
- D3_THROMBOCYTOPENIANAS
- DM_RETINOPATHY_EXMORE
- DRY_AMD_EARLY
- E4_ADDISON
- E4_ADRENAS
- E4_AMYL_ORGAN
- E4_CONGENITAL_HYPOTHYROIDISM_WITHOUT_GOITER
- E4_DIABINSIPIDUS
- E4_DM1
- E4_ENDONUTRMET
- E4_GRAVES_STRICT
- E4_IDIOPATHIC_HYPERCALCIURIA
- E4_IRON_MET
- E4_LACTOSEINT
- E4_MARASMUS
- E4_MINERAL_MET
- E4_NUTRIDEF
- E4_PHOS_MET
- E4_PITUDISNAS
- E4_PLASMAPROT
- E4_PORBILIRNAS
- E4_PUBDISNAS
- E4_SHORT
- E4_SHORT_STATURE_STARTING_BEFORE_BIRTH
- E4_TESTICDYSNAS
- E4_THYCRISIS
- E4_THYMUSDISNAS
- EPISEIZALCO
- F5_EATOTH
- F5_EMOPER
- F5_KELAMENT
- F5_MENTORG
- F5_MILDRET
- F5_PERSMOOD
- F5_PERSOCHANGE
- F5_SCHIZOAFF
- F5_SCHZPHR
- F5_SEDAHYP
- F5_SEVRET
- F5_SPEECH
- F5_STIMUL
- FG_OTHHEART
- G6_ALZHEIMER
- G6_CEROEDEMA
- G6_CLUSTHEADACHE_STRICT
- G6_HCOTHUNS
- G6_MENINGVIR
- G6_MONONPOTHUS
- G6_MYOTDIS
- G6_NEUATR
- G6_NMO
- G6_PARDIPLE
- G6_POLYNEU
- G6_POSTVIRFAT
- G6_POSTZOST
- G6_SCIALE
- GASTRO_OPERATIONS
- GE
- GE_MODE
- GLP1ANA
- H7_BCKRNDRETINOPAT
- H7_BINOCUMOVOTH
- H7_CHOROIDRETINA
- H7_CHORSCAR
- H7_CONJUNCTIVITIS
- H7_CONJUNCTIVITISACUNONATOPIC_WIDE
- H7_EYELIDINFLAMMATION
- H7_EYELIDINFLAMMATION_WIDE
- H7_GLAUCCLOSEPRIM
- H7_GLAUCPRIMOPEN
- H7_LENS
- H7_NYSTAGMUS
- H7_OTHENDOPHTHALMITIS
- H7_OTHERCONJ
- H7_POSTOPEYENAS
- H7_RETINANAS
- H7_VISDISTNAS
- H7_VITRBODYGLOBE
- H8_BPV
- H8_EXCESSIVE_EARWAX
- H8_EXT_MALIGN
- H8_HL_DEAFMUT
- H8_HL_NAS
- H8_MENIERE
- H8_OTIMEDNAS
- HEPATITIS_ACUTE_OTHER_VIRAL
- HERING_UNILATERAL
- HLP_C3_AML
- HLP_C3_ASTROCYTOMA
- I9_ANGIO
- I9_CARDMYOALC
- I9_CARDMYOHYP
- I9_CEREBDOTH
- I9_CONDUCTIO
- I9_HEARTFAIL_EXMORE
- I9_HYPTENSESS
- I9_HYPTENSPUL
- I9_HYPTENSRD
- I9_OTHILLHEART
- I9_PULMEMB
- I9_SAHANEUR
- I9_THROMBANG
- I9_VARICVEOES
- ILD_ENDPOINTS
- ILD_HOSPITAL_PULM_INFECT
- INCREASEDMUSCLETONE
- INSULIN_SHORTFAST
- INTERSTITIAL_CYSTIT_CHRONIC
- J10_ARDS
- J10_ASTHMA_EXMORE
- J10_CHRONRHINITIS
- J10_COPDNAS_INCLAVO
- J10_EXTERLUNG
- J10_INFLUPNEU
- J10_LOWERINF
- J10_PNEUMOBACT
- J10_PULMEOS
- J10_RESPDISOTH
- K11_ALCGASTR
- K11_APPENDECTOMY
- K11_APPENDOTH
- K11_CD_STRICT2
- K11_CHOLANGI
- K11_CHOLELITH
- K11_CONSTIPATION
- K11_EMBIMPACT_TEETH
- K11_FISSANAL
- K11_GIDISEASES
- K11_HYPOPLASIA_ENAMEL_INCLAVO
- K11_MAXIL_CANINE_OPER
- K11_MAXIL_CANINE_PALAT
- K11_MIH_CARIES
- K11_ORALCYST
- K11_OTHILEUS
- K11_PERIODONTAL_NOS
- K11_PULP_PERIAPICAL_INCLAVO
- K11_UC_STRICT2
- K11_ULCER
- K11_UMBHER
- KRA_PSY_CHILDOTH
- KRA_PSY_DEVWIDE
- KRA_PSY_EATING
- KRA_PSY_MOTOR_EXMORE
- KRA_PSY_SPEELING
- KRA_PSY_SPEELING_EXMORE
- L12_ACANTHNIGRICANS
- L12_ATROPHICSKIN
- L12_CHLOASMA
- L12_DERM_NAS
- L12_ERYTHEMANODOSUM
- L12_HAIRLOSS_SCARNAS
- L12_HYPERTRICHOSIS
- L12_INFECT_DERM
- L12_INTERNALSUBSTANCEDERM
- L12_OTHERSKINSUBCUTIS
- L12_PSORI_PUSTGEN
- L12_PSORI_VULG
- M13_ARTHROSIS_OTH
- M13_BURSELBOWOTH
- M13_CARTILAGE
- M13_DEFORMACQ
- M13_DEQUERVAIN
- M13_DERMATOMYOTH
- M13_DISSYNOTENDNAS
- M13_EARLY_LUMBAR_PROLAPSE
- M13_JUVERHEU
- M13_KNEEDERANGEMENTS
- M13_KNUCKLEPADS
- M13_OSTEOCHONDRO
- M13_OSTEOMYELITIS
- M13_OTERSPECARTHR
- M13_PROGRESSIVE_SYSTEMIC_SCLEROSIS
- M13_RELAPSPOLYCHONDR
- M13_SHOULDERBURSITIS
- M13_SPONDYLINFLAMNAS
- M13_SPONTRUPTSYNOTEND
- M13_SYSTCONNECT
- M13_SYSTSLCE
- M13_THORACISPINEPAIN
- M13_TIBIALCOLLATERAL
- M13_VERTEBCOLLAPSE
- MNMED_RILUZOLE
- N14_BARTHOABSCESS
- N14_CALCULOWER
- N14_ENDOMET_INFERT
- N14_FEMALEGENNONINF
- N14_MEMBRANOUS_NEPHROPATHY
- N14_MESNRUIRREG
- N14_OTHFEMPELINF
- N14_OTHNONINFVAG
- N14_PROSTHYPERPLA
- N14_URETHRITISANDURSYNDR
- N14_UTER_POLYP
- N14_VULVAL_HSIL
- O15_ANTEPART_HAEM_NAS
- O15_CONCEPT_ABNORM
- O15_DELIV_SPONT
- O15_ICP
- O15_PREG_BIRTH_PUERP
- O15_PRE_OR_ECLAMPSIA
- OFFICIAL_TILASTOKESKUS_DEATH
- OPER_JFB31
- PD2ND_EXMORE
- PDMED_PERGOLIDE
- PD_DEMENTIA_EXMORE
- PNEUMO_SEPTHICHE
- Q17_ASD
- Q17_AVSD
- Q17_CLEFT_HARD_PALATE_NOS
- Q17_CLEFT_LIP_CLEFT_PALATE
- Q17_CLEFT_PALATE
- Q17_CONGENITAL_PTOSIS
- Q17_CONGENITAL_VESICOURETERAL_REFLUX
- Q17_CONGEN_ICHTHYOSIS
- Q17_CONGEN_MALFO_LUNG
- Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED
- Q17_CONGEN_MALFO_OESOPHAGUS
- Q17_CYSTIC_DISEASE_OF_LIVER
- Q17_CYSTIC_KIDNEY_DISEA_WIDE
- Q17_ECTOPIC_TESTIS
- Q17_FAMILIAL_BENIGN_PEMPHIGUS
- Q17_FOLLICULAR_KERATOSIS_WIDE
- Q17_HYPOSPADIAS
- Q17_NEUROFIBROMATOSIS_1
- Q17_OSTEOGEN_IMPERFECTA
- Q17_OTHER_CONGEN_MALFO_BRAIN
- Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM
- Q17_OTHER_CONGEN_MALFO_INTEG_WIDE
- Q17_OTHER_CONGEN_MALFO_INTESTINE_WIDE
- Q17_OTHER_CONGEN_MALFO_WIDE
- Q17_REDUCT_DEFECTS_LOWER_LIMB
- Q17_SUPERNUMERARY_URETER
- Q17_TUBEROUS_SCLEROSIS
- R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
- R18_ABNORMAL_FINDI_EXAMI_URINE_WO_DIAGNOSIS
- R18_ABNORMAL_FINDI_NIPPLE_DISCH_SYNOVIAL_FLUID_WOUND_SECRE
- R18_DISTU_SMELL_TASTE
- R18_ENLARGED_LYMPH_NODES
- R18_OTHER_ABNORMALITI_PLASMA_PROTEINS
- R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_COGNITIVE_FUNCTIONS_AWARE
- R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_GENERAL_SENSA_PERCEP
- R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM
- R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT
- R18_SYMPTOMS_SIGNS_CONCERNI_FOOD_FLUID_INTAKE
- R18_SYMPTOMS_SIGNS_INVOLVI_COGNITION_PERCEP_EMOTIONAL_STATE_BEHVI
- R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM
- R18_UNSPE_HAEMATU
- RHEUMA_OTHER_WIDE
- RX_ASTMA_BIOL
- RX_CROHN_2NDLINE
- RX_GLUCOSAMINE
- RX_L01XE
- RX_OPIOIDS
- RX_TRAMADOL
- SPONDYLOARTHRITIS
- ST19_BURNS_CORROSIO_MULTIPLE_UNSPE_BODY_REGIONS
- ST19_BURN_CORROSION_ANKLE_FOOT
- ST19_BURN_CORROSION_BODY_REGION_UNSPE
- ST19_BURN_CORROSION_HIP_LOWER_LIMB_ANKLE_FOOT
- ST19_BURN_CORROSION_OTHER_INTERNAL_ORGANS
- ST19_BURN_CORROSION_WRIST_HAND
- ST19_COMPLICATIO_PECUL_REATTACHM_AMPUT
- ST19_EFFEC_OTHER_DEPRI
- ST19_FOREI_BODY_RESPI_TRACT
- ST19_FRACT_LOWER_LEG_INCLU_ANKLE
- ST19_INJURI_ABDOMEN_LOWER_BACK_LUMBAR_SPINE_PELVIS
- ST19_INJURI_THORAX
- ST19_INJURY_BLOOD_VESSE_LOWER_LEG_LEVEL
- ST19_INJURY_NERVES_LUMBAR_SPINAL_CORD_ABDOMEN_LOWER_BACK_PELVIS_LEVEL
- ST19_INJURY_POISO_CERTA_OTHER_CONSE_EXTER_CAUSES
- ST19_OPEN_WOUND_ANKLE_FOOT
- ST19_OTHER_INJURI_LOWER_LIMB_LEVEL_UNSPE
- ST19_OTHER_UNSPE_INJURI_ANKLE_FOOT
- ST19_OTHER_UNSPE_INJURI_LOWER_LEG
- ST19_POISO_MEDICI_ADVERSE
- ST19_SEQUEL_INJURI_NECK_TRUNK
- ST19_SUPERF_INJURY_HIP_THIGH
- ST19_SUPERF_INJURY_NECK
- ST19_TRAUMAT_SUBAR_HAEMORRHAGE
- T1D_WIDE2
- T2D
- THYGROWTHS
- TRIPTAN1
- VWXY20_DIVING_JUMPI_WATER_CAUSI_INJURY_OTHER_DROWN_SUBME
- VWXY20_INTENTI_SELF_H_JUMPI_LYING_MOVING_OBJECT
- VWXY20_JAAMI_PURISTUK_TAI_MURSK_JOUTU_ESINEI_SISAAN_TAI_VALIIN
- VWXY20_LIFESTYLE__CONDI
- VWXY20_MOTOR_NONMOTOR__ACCIDENT_TYPE_VEHIC_UNSPE_NONTRAF_ACCIDENT
- VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS
- VWXY20_OTHER_FACTOR_ENVIRONMENT
- VWXY20_PEDES_INJURED_COLLIS_W_OTHER_NONMOTOR_VEHIC
- VWXY20_PEDES_INJURED_COLLIS_W_PEDAL_CYCLE
- VWXY20_STERI_VAROT_PETTA_KIRURGISEN_TAI_MUUN_LAAKETIETEELLISEN_HOIDON_AIKANA
- Z21_FAMILY_HISTORY_OTH_SPECIFIC_DISORD
- Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA
- Z21_NEED_IMMUNI_SINGLE_BACTERIAL_DISEA
- Z21_OTHER_ORTHOPA_FOLLOW__CARE
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_CIRCUMSTANC_RELATED_REPRODUCTION
- Z21_PROBL_RELATED_CARE__DEPENDENCY
- Z21_PROCREATIVE_MANAG
- Z21_TOBAC_USE
- Z21_UPPER_ARM
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
826
3420
4.44
166.44
6.3
2.8
3.38
3.67
e6/l
0.42
786
3135
986
4823
4.51
153.28
11.0
3.7
365.08
95.66
e6/l
1.61
859
3818
888
4135
4.13
145.47
10.3
3.6
0.19
0.48
e6/l
8.98
769
3155
1002
5210
4.23
136.54
12.0
4.2
187.95
109.61
e6/l
1.08
883
3910
1316
8473
9.92
134.43
13.9
4.9
1592.24
1299.31
e6/l
0.06
29
147
1073
6564
3.70
98.86
6.5
4.1
0.00
0.00
estimate
-0.00
310
1452
1081
6667
3.71
97.77
6.6
4.1
0.02
4.28
estimate
1.33
320
1481
1078
6694
3.64
95.13
6.7
4.1
0.04
0.23
estimate
0.40
292
1359
378
1333
3.51
86.48
5.4
2.5
0.21
0.47
e6/l
2.40
373
1283
995
6126
3.15
83.94
3.6
3.1
—
—
estimate
—
0
0
565
2643
2.90
78.36
10.3
3.2
0.97
0.95
e6/l
0.05
420
1514
529
2440
2.88
74.64
11.1
3.4
1.01
1.19
e6/l
0.44
385
1306
1110
8133
2.75
52.66
5.9
5.7
6.86
6.94
mmol/l
0.74
1085
7815
649
3855
2.27
48.34
6.7
4.2
0.00
0.00
estimate
0.78
282
1271
591
3377
2.30
48.33
5.9
3.7
0.07
0.04
estimate
0.25
220
1119
760
4900
2.20
45.24
6.9
4.2
0.03
0.02
estimate
0.13
254
1218
560
3240
2.21
43.27
4.8
3.2
0.13
0.04
0.48
15
103
984
7200
2.23
40.44
21.6
20.2
1.33
1.37
inr
1.10
837
6096
1343
11447
5.05
39.99
25.8
20.8
31.47
29.60
mg/l
1.10
1208
9799
186
671
3.04
38.80
2.9
2.2
0.05
1.46
estimate
0.48
39
174
1370
12040
6.86
35.01
32.6
25.5
139.57
139.63
mmol/l
0.44
1358
11812
1370
12053
6.81
34.66
32.9
25.8
4.04
4.02
mmol/l
1.13
1358
11810
1373
12184
6.93
32.45
37.2
27.8
93.25
88.92
umol/l
3.02
1364
12029
1375
12240
7.18
31.82
40.0
31.1
92.00
92.03
fl
0.10
1365
12069
1375
12241
7.18
31.80
40.2
31.2
235.26
232.59
e9/l
0.86
1349
11949
1375
12241
7.18
31.80
40.8
31.8
39.87
40.08
%
0.75
1365
12062
1375
12241
7.18
31.80
40.2
31.2
4.41
4.43
e12/l
0.61
1346
11899
1375
12242
7.17
31.77
40.2
31.2
7.23
7.01
e9/l
3.12
1347
11902
1375
12243
7.17
31.74
40.5
31.4
132.56
134.41
g/l
3.87
1365
12077
1297
11122
3.20
31.57
28.8
20.5
70.77
73.40
ml/min/173m2
5.07
1254
10445
1351
12021
4.34
27.91
14.8
13.7
25.67
26.07
u/l
0.42
1314
11594
1008
7960
1.95
26.98
6.6
6.2
3.07
3.79
ug/l
0.45
924
7128
1167
9770
2.16
25.59
9.8
9.1
79.57
82.31
u/l
1.28
1118
9275
1096
9023
1.98
24.37
4.8
4.5
15.24
14.02
mm/h
1.41
1000
8336
1277
11233
2.52
22.60
5.9
5.6
4.18
4.27
mmol/l
2.30
1159
10287
1282
11308
2.55
22.35
6.4
5.9
6.27
6.16
mmol/l
2.08
1137
10179
909
7154
1.77
22.11
7.2
7.2
11.18
12.91
umol/l
6.48
879
6854
1294
11488
2.63
21.79
6.8
6.5
2.37
2.45
mmol/l
2.52
1172
10472
1267
11149
2.41
21.64
5.8
5.5
1.31
1.37
mmol/l
4.99
1138
10125
909
7190
1.75
21.34
9.6
9.8
4.67
4.42
e9/l
2.04
768
6196
1267
11172
2.38
21.13
8.6
7.6
41.48
40.63
mmol/mol
2.69
1164
10292
506
3423
1.75
20.82
3.1
2.7
—
—
—
0
0
820
6334
1.71
20.67
6.1
5.6
34.37
34.62
g/l
0.62
773
5920
1080
9118
1.80
18.70
33.5
25.6
13.98
13.92
%
0.67
1071
8993
889
7147
1.67
18.07
8.0
8.2
1.21
1.20
mmol/l
0.86
765
6130
583
4244
1.64
17.39
3.0
2.8
60.37
79.13
u/l
0.48
547
3937
1192
10497
1.90
16.42
5.4
4.9
2.01
2.06
mu/l
0.65
1043
9446
1211
10720
1.95
16.40
4.9
4.7
1.33
1.27
mmol/l
2.38
1066
9648
802
6415
1.58
15.48
5.2
5.1
21.37
21.93
%
0.50
459
3463
705
5484
1.57
15.28
17.0
13.1
0.00
0.00
e9/l
0.56
576
4466
481
3429
1.61
15.08
5.0
4.5
84.41
81.37
%
1.87
475
3362
716
5611
1.56
14.86
2.5
2.3
—
—
—
0
0
146
729
2.12
14.85
6.4
3.7
1.02
1.02
ratio
0.06
141
674
540
3974
1.58
14.72
2.7
2.4
2.98
2.93
mg/l
0.21
455
3405
258
1587
1.77
14.03
5.0
3.9
—
—
—
0
0
587
4458
1.54
13.64
1.8
1.8
19.17
19.45
nmol/l
0.16
484
3759
688
5411
1.53
13.60
3.6
3.2
155.70
179.74
ug/l
1.63
621
4945
600
4655
1.50
12.21
3.5
3.6
0.76
0.81
ug/l
0.77
455
3357
983
8490
1.53
11.52
4.3
3.8
15.06
15.05
pmol/l
0.07
856
7560
866
7295
1.49
11.38
3.3
3.5
54.63
60.26
u/l
0.91
798
6733
123
643
2.00
11.03
3.0
3.2
24.03
24.70
mmol/l
0.97
123
633
778
6454
1.46
10.79
7.4
7.3
1.21
1.20
mmol/l
1.20
710
5941
391
2848
1.52
10.40
2.0
2.0
—
—
—
0
0
350
2490
1.54
10.38
2.0
2.1
29.89
30.10
s
0.31
344
2422
351
2512
1.53
10.09
3.0
2.8
2.29
2.21
g/l
1.65
318
2325
626
5027
1.44
10.05
3.8
3.6
7.42
7.76
mmol/l
1.43
498
4184
333
2361
1.54
9.98
3.0
2.9
19.15
22.49
%
5.31
307
2205
633
5107
1.44
9.84
4.8
4.4
10.73
8.95
mg/mmol
0.38
435
3402
766
6402
1.43
9.79
2.4
2.3
92.64
92.44
pmol/l
0.04
436
3597
680
5606
1.41
9.13
5.3
4.5
265.28
84.31
ng/l
0.38
585
4553
362
2670
1.48
8.84
3.1
2.9
11.04
12.34
umol/l
3.16
335
2491
625
5112
1.40
8.61
3.7
3.4
2102.03
1812.92
ng/l
0.47
560
4530
177
1117
1.67
8.56
1.8
1.7
—
—
—
0
0
570
4609
1.40
8.31
4.1
3.6
2.34
2.34
mmol/l
0.11
517
4135
553
4476
1.39
7.91
2.5
2.3
258.21
242.43
u/l
0.11
519
4231
241
1690
1.51
7.41
3.8
4.2
20.17
28.96
ug/l
0.31
202
1428
475
3784
1.39
7.35
3.2
3.3
378.53
368.97
umol/l
1.07
385
3260
174
1162
1.57
6.66
4.4
4.3
1.22
1.22
mmol/l
0.42
151
1011
377
2941
1.39
6.47
7.4
4.3
1.02
1.02
kg/l
0.00
300
2020
35
136
2.61
6.40
1.3
1.4
—
—
—
0
0
347
2686
1.39
6.21
1.8
1.7
1.41
1.66
mg/l
0.70
275
2142
287
2156
1.42
6.11
1.9
1.9
—
—
—
0
0
74
405
1.87
5.88
2.3
2.3
124.68
129.30
g/l
0.73
57
319
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
105
638
1.70
5.87
3.7
2.8
0.35
0.33
iu/ml
0.21
54
351
267
1995
1.42
5.84
1.9
2.0
—
—
—
0
0
149
998
1.55
5.63
3.9
3.7
1.26
1.91
mmol/l
1.57
115
731
620
5301
1.30
5.54
2.4
2.3
77.41
77.96
nmol/l
0.18
533
4650
72
405
1.82
5.27
2.4
2.3
202.62
106.46
ug/min
0.37
36
246
356
2852
1.33
4.98
3.7
3.2
2.47
2.45
mmol/l
1.83
325
2551
65
363
1.83
4.89
2.7
2.7
15.68
16.10
%
0.51
65
355
227
1708
1.39
4.72
2.4
2.7
63.45
67.94
e9/l
1.27
180
1281
265
2047
1.36
4.69
3.6
4.4
227.88
249.68
u/l
3.12
252
1934
488
4131
1.28
4.45
3.0
3.3
43.37
36.74
u/l
0.41
459
3884
101
658
1.58
4.34
3.2
2.7
—
—
—
0
0
223
1701
1.37
4.26
7.0
8.6
120.82
121.16
g/l
0.08
216
1661
357
2925
1.30
4.16
5.1
4.4
311.58
660.37
ng/l
0.60
314
2580
74
453
1.67
4.10
1.8
1.8
—
—
—
0
0
67
402
1.70
4.00
1.7
1.5
—
—
—
0
0
267
2116
1.32
3.95
6.5
6.7
1.04
1.03
mmol/l
0.14
253
1979
559
4873
1.24
3.83
2.0
2.0
1.39
1.29
mmol/l
1.92
435
3961
27
121
2.26
3.75
1.3
1.2
—
—
—
0
0
27
122
2.24
3.68
1.3
1.3
—
—
—
0
0
151
1109
1.41
3.63
8.1
9.6
0.52
0.63
%
3.50
151
1099
208
1610
1.34
3.61
7.0
7.6
11.51
11.44
mmol/l
0.04
202
1543
154
1141
1.39
3.52
8.2
9.5
94.23
93.85
%
0.30
154
1136
65
402
1.65
3.50
3.8
3.8
2.08
1.68
index
0.27
37
224
139
1015
1.41
3.46
7.3
10.6
16.15
15.85
%
0.62
133
976
188
1445
1.35
3.42
1.8
2.3
0.21
0.20
g/l
0.88
173
1335
31
154
2.04
3.37
1.5
1.6
22.82
37.09
ng/l
1.03
31
154
166
1255
1.37
3.36
2.6
2.5
36.95
37.91
u/l
0.07
145
1051
118
841
1.44
3.36
1.5
1.5
—
—
—
0
0
366
3080
1.25
3.35
1.9
1.8
436.07
15049928.53
pmol/l
1.46
285
2525
154
1151
1.38
3.35
8.0
9.3
1.21
1.29
%
0.53
154
1141
202
1577
1.33
3.31
2.6
2.9
10.52
9.92
umol/l
0.08
179
1430
232
1857
1.30
3.18
6.9
7.9
95.78
95.32
%
0.55
225
1791
49
291
1.71
3.10
1.3
1.3
—
—
—
0
0
333
2797
1.25
3.08
1.9
1.8
1166.64
1149.35
nmol/l
0.12
232
2118
216
1724
1.30
3.02
4.0
3.8
1.30
1.93
mmol/l
1.84
188
1478
149
1130
1.36
2.97
3.0
3.1
55.61
59.85
ml/min/173m2
0.68
62
507
55
342
1.63
2.95
1.7
1.5
26.94
25.02
u/ml
0.06
11
60
87
604
1.47
2.87
2.2
1.8
—
—
—
0
0
24
116
2.09
2.83
2.2
1.8
3.12
1.23
u/field
0.37
17
62
149
1139
1.34
2.83
3.4
2.3
353.71
380.58
nmol/l
0.78
141
1051
113
826
1.40
2.83
1.7
1.9
1.50
2.29
ug/l
0.35
105
732
301
2523
1.25
2.82
3.8
3.4
0.81
0.82
mmol/l
0.36
281
2385
78
534
1.49
2.77
2.9
3.6
4.34
4.34
pmol/l
0.00
73
462
65
428
1.54
2.76
4.0
3.5
1.60
1.61
mmol/l
0.03
65
414
952
8938
1.20
2.65
35.2
27.5
331.07
332.17
g/l
3.13
945
8889
41
243
1.71
2.65
1.4
1.3
8.88
7.43
u/l
0.51
34
191
246
2033
1.25
2.60
6.8
7.8
0.25
0.88
mmol/l
1.82
201
1653
56
362
1.57
2.60
4.3
3.6
7.82
7.60
mmol/l
0.22
56
349
247
2050
1.25
2.52
6.8
7.8
5.05
5.08
kpa
0.20
238
1966
247
2051
1.25
2.51
6.8
7.8
12.25
11.73
kpa
0.86
238
1969
36
211
1.72
2.44
3.0
6.4
7.51
7.45
mmol/l
0.04
30
175
64
433
1.50
2.44
2.7
2.8
1.77
1.79
mg/l
0.06
57
374
0
66
0.00
2.41
0.0
1.0
—
—
—
0
0
29
161
1.82
2.36
3.2
2.8
—
—
—
0
0
22
112
1.98
2.31
1.4
1.3
27.03
23.62
iu/l
0.22
15
92
89
654
1.39
2.21
2.3
2.0
—
—
—
0
0
5
9
5.57
2.21
2.8
2.0
0.40
0.44
u/field
—
5
9
97
725
1.36
2.18
3.1
2.6
3.73
3.73
g/l
0.01
83
666
97
725
1.36
2.18
3.1
2.6
4.38
4.10
g/l
1.23
83
668
97
725
1.36
2.18
3.1
2.6
7.26
7.34
g/l
0.15
83
666
42
266
1.60
2.16
1.6
1.7
15.69
22.55
ug/l
1.42
42
261
34
204
1.68
2.15
1.9
1.9
90.06
89.23
%
0.40
34
204
7
19
3.70
2.15
1.4
1.4
—
—
—
0
0
243
2053
1.22
2.10
1.5
1.6
3.07
2.93
g/l
0.25
146
1233
28
160
1.77
2.10
1.5
1.6
61.69
65.14
%
0.16
16
98
82
604
1.38
2.03
4.1
3.4
62.88
6878.43
u/ml
0.87
73
520
21
111
1.91
2.01
1.2
1.3
—
—
—
0
0
116
907
1.30
1.95
1.6
1.8
1.64
1.52
g/l
0.70
107
780
82
610
1.37
1.92
4.7
4.1
24.36
24.79
mmol/l
0.86
76
563
89
674
1.34
1.87
3.2
2.6
2.87
2.98
g/l
0.40
75
616
6
17
3.54
1.84
1.5
1.2
317.95
100.47
ng/l
—
6
11
52
360
1.46
1.83
2.4
3.4
536.31
1063.98
u/ml
0.31
47
337
256
2205
1.20
1.82
1.3
1.2
2.24
1.65
u/ml
0.25
59
556
55
386
1.44
1.81
1.4
1.5
256.47
249.43
ug/g
0.07
29
249
70
515
1.38
1.78
1.2
1.4
—
—
—
0
0
22
125
1.77
1.72
2.3
2.3
845.67
632.85
ml
—
6
80
103
809
1.29
1.70
4.4
5.6
1.70
1.59
%
0.46
98
764
44
302
1.47
1.64
1.5
1.6
32.71
31.41
g/l
0.28
39
272
177
1493
1.21
1.58
2.8
2.8
65.66
66.11
g/l
0.35
159
1377
6
20
3.01
1.58
1.2
1.9
—
—
—
0
0
7
157
0.44
1.55
1.3
1.9
—
—
—
0
0
173
1465
1.21
1.50
2.9
2.5
6.82
7.79
ug/l
0.33
157
1316
28
179
1.58
1.46
1.6
1.7
269.50
279.65
mu/l
0.05
28
168
81
631
1.30
1.45
3.4
2.6
9.53
10.88
g/l
2.32
66
568
18
102
1.77
1.45
1.1
1.1
0.39
1.06
u/ml
—
10
59
134
1115
1.22
1.39
1.7
1.7
—
—
—
0
0
46
335
1.39
1.30
1.5
1.5
—
—
—
0
0
44
318
1.40
1.30
1.3
1.3
—
—
—
0
0
44
318
1.40
1.30
1.3
1.3
—
—
—
0
0
41
293
1.41
1.29
3.6
3.8
38.02
31.76
mg/l
0.34
28
205
35
243
1.45
1.28
5.1
3.2
27.83
115.08
u/ml
1.02
35
233
5
18
2.78
1.28
2.2
3.3
62.72
145.46
pmol/l
—
5
18
130
1090
1.21
1.27
3.9
4.4
107.26
102.74
ng/l
0.19
104
948
58
441
1.33
1.26
1.3
1.6
—
—
—
0
0
31
211
1.48
1.26
1.3
1.8
1.51
4.76
iu/l
—
6
88
8
36
2.23
1.24
2.0
1.4
—
—
—
0
0
35
245
1.44
1.24
1.1
1.1
—
—
—
0
0
170
1471
1.18
1.19
2.3
2.3
10.71
12.85
nmol/l
3.16
151
1285
8
38
2.11
1.18
1.3
3.2
3.50
812.34
ug/l
—
8
38
13
72
1.81
1.15
1.0
1.0
—
—
—
0
0
22
142
1.56
1.14
1.1
1.3
0.22
0.19
nmol/l
0.48
17
116
128
1085
1.20
1.14
1.2
1.3
—
—
—
0
0
14
80
1.76
1.13
1.0
1.2
—
—
—
0
0
40
293
1.38
1.12
1.1
1.3
—
—
—
0
0
7
30
2.34
1.12
1.9
1.1
1.14
1.17
mmol/l
—
7
30
11
58
1.90
1.12
1.6
3.0
4.91
4.92
kpa
0.01
11
58
11
58
1.90
1.12
1.6
3.0
9.57
10.40
kpa
0.62
11
58
28
192
1.47
1.12
4.0
4.0
—
—
—
0
0
9
165
0.54
1.08
1.3
1.8
—
—
—
0
0
74
596
1.26
1.08
4.1
3.4
1.38
3.06
ratio
1.50
44
356
48
365
1.33
1.07
1.5
1.6
—
—
—
0
0
117
993
1.19
1.04
4.4
3.8
23.71
24.21
mmol/l
1.18
117
981
124
1058
1.19
1.04
1.5
1.4
—
—
—
0
0
7
34
2.06
1.03
1.3
1.6
1.89
1.46
ratio
—
7
29
14
83
1.69
1.01
4.8
4.2
72.36
124.87
nmol/l
1.60
14
83
59
467
1.27
1.00
1.1
1.1
103.37
143.35
u/ml
0.36
15
157
7
35
2.00
1.00
1.0
1.1
—
24.80
u/ml
—
0
5
19
123
1.55
1.00
1.3
1.3
15.44
23.87
%
1.09
12
74
77
630
1.24
0.99
3.7
2.6
1.39
1.33
g/l
0.04
61
546
7
135
0.52
0.98
1.7
1.7
—
—
—
0
0
7
135
0.52
0.98
1.7
1.7
—
—
—
0
0
7
135
0.52
0.98
1.7
1.7
—
—
—
0
0
32
232
1.39
0.98
4.4
4.4
11.88
10.95
pmol/l
0.14
32
232
21
141
1.50
0.95
1.3
1.2
107.43
199.55
miu/ml
—
7
39
6
29
2.07
0.89
2.8
2.3
—
—
—
0
0
29
211
1.38
0.88
1.4
1.6
—
—
—
0
0
47
369
1.28
0.88
1.6
1.6
—
—
—
0
0
6
30
2.00
0.87
2.8
2.3
—
—
—
0
0
6
31
1.94
0.84
2.0
1.5
112.67
86.81
nmol/24h
—
6
31
32
240
1.34
0.83
1.3
1.3
—
—
—
0
0
51
409
1.26
0.82
1.4
1.4
—
—
—
0
0
16
105
1.53
0.81
1.0
1.0
—
—
—
0
0
21
294
0.71
0.80
1.6
1.6
10.65
4.03
mg/l
0.60
15
228
78
657
1.20
0.80
4.2
3.6
70.77
89.00
mg/l
0.25
62
555
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
78
659
1.19
0.77
4.2
3.6
65.05
62.41
mg/l
0.06
62
554
17
115
1.48
0.77
1.1
1.5
—
—
—
0
0
9
53
1.70
0.75
1.4
1.3
21.09
24.07
u/l
—
9
43
12
75
1.61
0.75
1.2
2.1
—
—
—
0
0
20
141
1.42
0.74
1.3
1.6
—
—
—
0
0
188
1703
1.12
0.74
5.7
5.4
33.11
32.46
%
0.33
116
1097
27
204
1.33
0.69
2.7
2.4
1872.10
201.60
u/ml
0.51
27
197
47
383
1.24
0.68
1.3
1.4
—
—
—
0
0
30
231
1.31
0.68
1.3
1.5
41038.24
91416.02
e6/l
0.65
17
138
11
70
1.58
0.65
1.4
1.4
—
—
—
0
0
30
233
1.29
0.65
1.2
1.3
—
19.07
—
0
7
14
95
1.48
0.64
1.1
1.4
1.96
1.04
promille
—
9
78
14
95
1.48
0.64
3.1
3.3
—
—
—
0
0
43
351
1.23
0.63
5.6
8.0
104.87
105.53
mmol/l
0.51
38
314
20
147
1.37
0.62
1.5
1.3
7451.00
206173.73
e6/l
1.76
12
98
22
290
0.75
0.61
1.3
1.2
4.05
3.86
mmol/l
0.23
22
268
155
1409
1.11
0.60
3.7
3.1
264.08
241.69
ng/l
0.25
145
1305
79
688
1.16
0.59
1.3
1.4
27.42
60.47
au/ml
—
5
55
48
402
1.20
0.56
1.6
1.6
13433.41
18996.44
e6/l
0.70
32
276
6
37
1.62
0.55
1.0
1.5
70.00
127.48
nmol/l
—
6
25
14
99
1.42
0.54
1.1
1.5
—
—
—
0
0
18
134
1.35
0.53
3.8
3.8
14.33
11.17
index
0.33
12
80
10
66
1.52
0.52
1.0
1.1
—
—
—
0
0
16
117
1.37
0.52
1.8
2.2
8.64
7.62
mmol/l
0.74
16
117
6
97
0.62
0.52
1.0
1.1
—
—
—
0
0
33
270
1.23
0.50
1.4
1.3
1.17
0.82
nmol/l
1.51
24
218
12
84
1.43
0.49
1.8
1.5
87.42
95.38
umol/l
0.53
12
84
19
145
1.31
0.49
1.6
1.3
1.44
1.49
g/l
0.28
19
145
26
208
1.25
0.48
1.2
1.2
275.20
312.18
u/ml
—
10
112
5
84
0.59
0.45
1.2
1.2
—
80.33
—
0
6
14
103
1.36
0.45
1.1
1.5
—
—
—
0
0
7
51
1.37
0.44
1.0
1.2
5.74
21.09
umol/l
—
7
35
23
285
0.80
0.43
1.7
1.3
11.69
37.88
e6/l
0.62
16
220
46
397
1.16
0.42
1.6
1.8
44.22
45.51
nmol/l
0.17
46
373
119
1093
1.10
0.41
6.8
7.2
24.43
24.39
mmol/l
0.04
112
1043
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
26
315
0.82
0.41
1.0
1.2
—
—
—
0
0
23
186
1.24
0.40
1.1
1.1
1.00
27.57
iu/ml
—
7
32
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
4739.25
—
0
12
0
18
0.00
0.40
0.0
4.9
—
—
—
0
0
121
1116
1.09
0.39
1.4
1.8
1.64
1.65
%
0.06
95
920
57
504
1.14
0.39
1.2
1.3
—
—
—
0
0
26
311
0.83
0.37
4.8
5.9
2739.60
775.64
iu/ml
—
5
45
24
289
0.83
0.36
1.8
1.3
658.44
682.21
e6/l
0.01
18
232
5
76
0.66
0.35
1.2
1.2
86.20
98.80
u/l
—
5
66
9
126
0.71
0.35
1.0
1.1
—
—
—
0
0
31
264
1.18
0.35
1.4
1.5
1291.43
4845.49
e6/l
0.56
23
188
27
319
0.84
0.34
1.0
1.2
—
—
—
0
0
13
167
0.78
0.34
1.4
1.4
—
—
—
0
0
18
145
1.24
0.33
1.3
1.2
1.20
1.56
nmol/l
1.03
18
131
14
109
1.29
0.33
1.1
1.4
—
51.11
—
0
9
13
166
0.78
0.33
1.4
1.5
—
—
—
0
0
13
166
0.78
0.33
1.4
1.5
—
—
—
0
0
11
83
1.33
0.32
2.4
2.0
—
—
—
0
0
27
315
0.85
0.31
1.3
1.5
—
—
—
0
0
7
98
0.71
0.31
1.0
1.0
285.43
283.02
mg/l
—
7
88
14
111
1.26
0.30
1.2
1.4
—
—
—
0
0
14
173
0.81
0.28
1.1
1.2
—
7.20
—
0
5
14
172
0.81
0.27
1.1
1.5
—
—
—
0
0
16
193
0.83
0.26
1.1
1.1
1.56
1.58
g/l
0.04
16
179
8
67
1.20
0.26
2.1
1.2
—
—
—
0
0
41
367
1.12
0.26
1.5
1.5
1.35
20.12
iu/ml
0.52
11
67
17
141
1.21
0.26
2.0
1.6
—
—
—
0
0
5
74
0.67
0.26
1.0
1.2
—
—
—
0
0
5
74
0.67
0.26
1.0
1.2
—
—
—
0
0
16
133
1.21
0.24
1.5
1.8
3.34
5.00
mg/l
2.46
16
128
6
81
0.74
0.24
5.2
1.9
0.39
0.69
e9/l
—
6
76
12
97
1.24
0.23
1.5
2.5
—
—
—
0
0
10
79
1.27
0.22
1.1
1.2
—
—
—
0
0
26
294
0.88
0.21
1.5
1.8
—
—
—
0
0
124
1179
1.06
0.21
2.3
2.3
146.66
170.13
ug/g
0.40
100
939
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
12
98
1.23
0.21
1.2
1.2
—
—
—
0
0
29
324
0.89
0.20
1.1
1.2
—
32.19
—
0
9
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
9
113
0.80
0.20
1.0
1.1
—
—
—
0
0
12
144
0.83
0.20
1.4
1.3
2.57
3.79
u/ml
—
7
52
12
99
1.21
0.19
1.2
1.2
—
—
—
0
0
11
133
0.83
0.19
1.3
1.7
—
1373.33
—
0
6
36
395
0.91
0.19
1.1
1.3
—
—
—
0
0
6
52
1.15
0.19
1.2
1.1
—
—
—
0
0
6
53
1.13
0.18
1.2
1.4
34.33
28.22
umol/l
—
6
47
7
58
1.21
0.18
2.0
1.5
—
—
—
0
0
28
310
0.90
0.17
1.1
1.2
2.80
3.62
u/ml
—
5
37
7
61
1.15
0.17
1.1
2.1
770.00
1370.92
u/ml
—
7
61
7
62
1.13
0.17
1.3
1.5
6.03
9.35
u/l
—
7
52
5
69
0.72
0.17
1.2
1.2
17.60
23.86
u/l
—
5
58
80
759
1.06
0.16
2.7
2.5
16.18
15.04
au/ml
—
5
54
8
70
1.14
0.16
1.0
1.6
42.84
39.05
g/l
—
8
70
6
78
0.77
0.15
2.0
2.0
—
—
—
0
0
6
80
0.75
0.15
1.8
1.9
—
—
—
0
0
6
80
0.75
0.15
1.8
1.9
—
—
—
0
0
6
80
0.75
0.15
1.8
1.9
—
—
—
0
0
6
80
0.75
0.15
1.8
1.9
—
—
—
0
0
9
80
1.13
0.15
1.1
1.2
—
—
—
0
0
43
461
0.93
0.15
1.5
1.6
0.22
0.34
mg/l
1.49
24
214
29
316
0.92
0.14
1.6
1.6
—
—
—
0
0
10
84
1.19
0.14
1.1
1.2
—
—
—
0
0
10
84
1.19
0.14
1.1
1.2
—
—
—
0
0
8
99
0.81
0.13
1.0
1.0
—
—
—
0
0
42
448
0.94
0.13
1.6
1.7
10.56
7.61
iu/ml
0.29
11
108
25
273
0.91
0.13
1.3
1.5
—
—
—
0
0
58
611
0.95
0.12
2.3
2.1
3.32
3.48
ratio
0.54
48
506
57
543
1.05
0.11
1.8
1.8
34.85
37.82
u/l
0.62
46
465
24
221
1.09
0.11
1.5
1.6
—
—
—
0
0
177
1729
1.03
0.11
1.2
1.3
14.18
12.51
u/ml
0.11
54
616
22
202
1.09
0.10
2.0
2.4
19.33
18.19
mg/l
—
6
77
39
412
0.95
0.10
2.0
1.9
3.25
3.32
mmol/l
0.13
28
311
6
54
1.11
0.09
4.3
4.9
13.48
13.45
%
—
6
54
49
469
1.05
0.08
4.8
4.0
4.01
3.99
mmol/l
0.10
49
461
13
144
0.90
0.08
1.3
1.2
12.43
8.28
u/ml
—
7
68
187
1837
1.02
0.08
1.3
1.3
34.81
39.90
iu/ml
0.14
62
551
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
75
0.80
0.07
1.2
1.1
—
—
—
0
0
7
80
0.87
0.07
1.4
1.3
115.53
163.46
pmol/l
—
7
80
15
163
0.92
0.07
2.1
2.6
1428.47
911.59
mg
0.32
15
163
41
393
1.04
0.07
1.0
1.0
—
—
—
0
0
9
88
1.02
0.07
2.8
2.4
—
—
—
0
0
20
213
0.94
0.06
1.2
1.3
—
—
—
0
0
11
100
1.10
0.05
1.4
1.4
—
—
—
0
0
166
1638
1.02
0.05
7.9
8.3
—
—
—
0
0
11
101
1.09
0.04
1.4
1.4
—
—
—
0
0
42
432
0.97
0.03
1.5
1.7
—
—
—
0
0
10
92
1.09
0.03
1.1
1.1
—
—
—
0
0
54
529
1.02
0.03
3.7
2.6
0.23
0.03
g/l
0.62
49
479
15
142
1.06
0.02
1.9
1.2
—
—
—
0
0
33
339
0.97
0.02
1.3
1.9
11.43
12.65
mg/l
0.28
27
308
18
172
1.05
0.02
1.1
1.0
—
—
—
0
0
37
361
1.03
0.02
1.4
1.5
—
—
—
0
0
42
429
0.98
0.02
1.5
1.6
—
—
—
0
0
12
126
0.95
0.00
1.2
1.1
—
—
—
0
0
31
312
0.99
0.00
1.3
1.5
—
—
—
0
0
10
101
0.99
0.00
1.2
1.1
2.84
2.15
mmol/l
—
10
93
51
512
1.00
0.00
3.8
2.5
0.00
0.00
g/l
-0.00
45
453
17
171
0.99
0.00
1.4
1.4
—
—
—
0
0
11
107
1.03
0.00
2.2
2.3
19.00
43.84
iu/ml
—
5
17
13
133
0.98
0.00
1.1
1.1
—
58.78
—
0
9
17
173
0.98
0.00
1.4
1.4
—
—
—
0
0
17
173
0.98
0.00
1.4
1.4
—
—
—
0
0
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
8
86
0.93
0.00
1.1
1.3
—
—
—
0
0
8
86
0.93
0.00
1.1
1.3
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.4
—
—
—
0
0
7
71
0.99
-0.00
1.6
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
54.42
—
0
5
7
71
0.99
-0.00
1.6
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.04
—
0
5
5
57
0.88
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.2
—
—
—
0
0
8
83
0.96
-0.00
6.3
3.3
0.63
0.88
%
—
8
83
0
9
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.33
—
0
6
0
5
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
383.40
—
0
5
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
87
0.92
-0.00
1.0
1.3
91.75
93.08
pmol/l
—
8
87
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
51
0.98
-0.00
1.6
2.3
0.56
0.61
mmol/l
—
5
51
8
80
1.00
-0.00
1.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BLADDER – Carcinoma in situ, bladder
GWS hits: 3
This endpoint is excluded from FinRegistry analyses (omitted endpoint).